Proton Pump Inhibitors, H(2) Blocker Use, and Risk of Inflammatory Bowel Disease in Children

OBJECTIVES: Evidence suggests use of proton pump inhibitors (PPIs) and H(2) blockers may provoke disease flares in individuals with established inflammatory bowel disease (IBD); however, there are no studies investigating the relationship of these medications with risk of developing pediatric IBD. T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pediatr Pharmacol Ther
Main Authors: Schwartz, Naomi R. M., Hutfless, Susan, Herrinton, Lisa J., Amsden, Laura B., Fevrier, Helene B., Giefer, Matthew, Lee, Dale, Suskind, David L., Delaney, Joseph A. C., Phipps, Amanda I.
Formato: Artigo
Idioma:Inglês
Publicado em: Pediatric Pharmacy Advocacy Group 2019
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836698/
https://ncbi.nlm.nih.gov/pubmed/31719810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-24.6.489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados